Speaker illustration

undefined undefined undefined

Cholesterol efflux capacity and subclinical atherosclerosis: is its impact greater in early stages?

Event: ESC Congress 2025

Topic: Biomarkers

Session: Novel biomarkers for cardiovascular risk assessment

Thumbnail

ESC 365 is supported by